What is the market price of each dose of tilsiparatide/tilpotide in 2025?
Tirzepatide is a new antidiabetic drug that acts as an agonist at both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. This drug is primarily used to improve blood sugar control in adults with type 2 diabetes as an adjunct to a low-calorie diet and increased physical activity. Due to its dual mechanism, tilsiparatide can effectively promote insulin secretion and inhibit glucagon release, thereby helping patients better manage their blood sugar levels.
In clinical studies, tilsiparatide has been shown to have significant effects in reducing hemoglobinA1c (HbA1c) levels and weight loss, making it an important treatment option for patients with type 2 diabetes. However, tilsiparatide is not currently available in the Chinese market, so patients need to obtain the drug through regular overseas channels. For patients who wish to use tisiparatide, they can choose to purchase the original drug from overseas.

According to market information, the price of overseas tilsiparatide original drug varies according to different regions and specifications. For example, in the European market, the specification of tisiparatide is 5mg/0.5mL injection, each box contains 4 tubes, and the price may be around 4,000 yuan. Another injection pen with a specification of 5mg*4 doses may cost more than 3,000 yuan per box. Please note that these prices will fluctuate due to exchange rate fluctuations, import fees and related policies. When deciding to purchase through overseas channels, patients should carefully choose legal and reputable pharmaceutical suppliers to ensure they receive safe and effective medications.
In short, tilsiparatide, as an innovative treatment for type 2 diabetes provides patients with a new choice. It has a positive impact on patients' overall health by improving blood sugar control and assisting in weight loss. Although it has not yet been launched in China, as the global awareness of this drug increases, it is expected to be promoted and applied in more countries and regions in the future.
Reference materials:https://www.drugs.com/tirzepatide.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)